---
title: "Publications"
layout: page
---
<details open>
  <summary><b>Patient-reported outcomes (PROs):</b></summary>

  SPIRIT-PRO extension (PRO-specific protocol guidance):  [Calvert et al, 2018]    (https://pubmed.ncbi.nlm.nih.gov/29411037/)
  
  SISAQOL recommendations (statistical standards for PRO data in randomized trials):  [Coens et al, 2020](https://pubmed.ncbi.nlm.nih.gov/32007209/)
  
  CONSORT-PRO extension:  [calvert et al, 2013](https://pubmed.ncbi.nlm.nih.gov/23443445/)
  
  PRO-cision Medicine Toolkit (Medical Care edition focused on PROs implemented in clinical practice):
  
  [Snyder et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30985589/)
  
  [Shi et al, 2016](https://pubmed.ncbi.nlm.nih.gov/30985590/)
  
  [Cook et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30985591/)
  
  [Brown & Cano, 2019](https://pubmed.ncbi.nlm.nih.gov/30985592/)
  
  [Jensen & Bjorner, 2019](https://pubmed.ncbi.nlm.nih.gov/30985593/)
  
  [Oliver et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30985594/)
  
  [King et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30985595/)
  
  [Blackford et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30985596/)
  
  [Haverman et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30985597/)
  
  [Absolom et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30985598/)
  
  [Zahrieh et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30985599/)
  
  [Barbera & Moody, 2019](https://pubmed.ncbi.nlm.nih.gov/30985600/)
  
  [Girgis et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30985601/)
  
  [Stover et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30985602/)

</details>

<details open>
  <summary><b>PROMIS:</b></summary>

  PROMIS scales to PRO-CTCAE and single-item numeric rating scale items:  [Lee et al, 2020](https://pubmed.ncbi.nlm.nih.gov/33305344/)
  
  PROMIS reporting recommendations: [Hanmer et al, 2020](https://pubmed.ncbi.nlm.nih.gov/32215788/)
</details>

<details open>
  <summary><b>PRO-CTCAE:</b></summary>

  Item generation:  [Basch et al, 2014](https://pubmed.ncbi.nlm.nih.gov/25265940/)
  
  Cognitive testing:  [Hay et al, 2013](https://pubmed.ncbi.nlm.nih.gov/23868457/)
  
  Validity, reliability, & responsiveness:  [Dueck et al, 2015](https://pubmed.ncbi.nlm.nih.gov/26270597/)
  
  Comparison of modes of administration (paper, web, & automated telephone):  [Bennett et al, 2016](https://pubmed.ncbi.nlm.nih.gov/26892667/) 
  Assessment of patient recall from 1 to 4 weeks:  [Mendoza et al, 2017](https://pubmed.ncbi.nlm.nih.gov/28545337/)
  
  Pediatric (and proxy) PRO-CTCAE:  [Reeve et al, 2017](https://pubmed.ncbi.nlm.nih.gov/28062347/)
  
  US FDA & NCI view on clinical review, IND safety reporting, & site inspections:  [Kim et al, 2018](https://pubmed.ncbi.nlm.nih.gov/29237718/)
  
  Strategy to select symptomatic AEs for administration:  [Trask et al, 2018](https://pubmed.ncbi.nlm.nih.gov/30230365/)
  
  What do “Mild”, “Moderate”, … mean to patients?:  [Atkinson et al, 2018](https://pubmed.ncbi.nlm.nih.gov/29129739/)
  
  Use of free text items:  [Chung et al, 2019](https://pubmed.ncbi.nlm.nih.gov/30840079/)
  
  Feasibility of PRO-CTCAE reporting:  [Basch et al, 2017](https://pubmed.ncbi.nlm.nih.gov/28463161/); and  [Basch et al, 2018](https://pubmed.ncbi.nlm.nih.gov/30204536/)
  
  Composite scoring algorithm:  [Basch et al, 2021](https://pubmed.ncbi.nlm.nih.gov/33258687/)
  
  Example of PRO-CTCAE in a trial (PRO-CTCAE is reported in the supplemental appendix):  [Gounder et al, 2018](https://pubmed.ncbi.nlm.nih.gov/30575484/)
  
  PRO-CTCAE baseline adjustment method:  [Dueck et al, 2020](https://pubmed.ncbi.nlm.nih.gov/31556911/)
</details>

<details open>
  <summary><b>Adverse event (AE) analysis:</b></summary>
  
  Lancet Haematology Commission on modernizing approach to AEs:  [Thanarajasingam et al, 2018](https://pubmed.ncbi.nlm.nih.gov/29907552/)
  
  Update to Lancet Haematology Commission:  [Thanarajasingam et al, 2022](https://pubmed.ncbi.nlm.nih.gov/35483398/)
  
  Thanarajasingam ToxT references:
  
    [Thanarajasingam et al, 2016](https://pubmed.ncbi.nlm.nih.gov/27083333/)
    
    [Thanarajasingam et al, 2016](https://pubmed.ncbi.nlm.nih.gov/27396640/)
    
    [Thanarajasingam et al, 2020](https://pubmed.ncbi.nlm.nih.gov/32470440/)
    
    [Wong et al, 2021](https://pubmed.ncbi.nlm.nih.gov/32951293/)

</details>

<details open>
  <summary><b>Rare diseases:</b></summary>
  
  [Boyd et al, 2016](https://pubmed.ncbi.nlm.nih.gov/26868354/)
  
  [Blay et al, 2016](https://pubmed.ncbi.nlm.nih.gov/26868355/)
  
  [Billingham et al, 2016](https://pubmed.ncbi.nlm.nih.gov/26868356/)

</details>



